CAR t cell patients monitored for years to uncover Long-Term effects
NCT ID NCT05024175
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 31 times
Summary
This study follows 45 adults who previously received CAR T cell therapy in earlier trials. Researchers will track their health for years using scans, blood tests, and physical exams to see how long the treatment's effects last and whether any late side effects appear. The goal is to better understand the long-term safety and success of CAR T cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CAR T cells
What this could lead to
If successful, this study will provide crucial data on the long-term safety and effectiveness of CAR T cell therapy, helping to improve future treatments.
What could go wrong
This is an observational follow-up study, not a new treatment trial. It cannot prove that CAR T cells work long-term, and results may be limited by the small number of participants.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.